The Uganda Virus Research Institute has been selected as one of the reference labs for COVID-19 in Africa. This is on top of being an Africa Centres for Disease Control (AFRICA CDC) reference lab. UVRI is now part of the sequencing laboratory network in Africa and will be providing genetic information needed for the swift and effective control of COVID-19 and other emerging pathogens.
The Uganda Virus Research Institute (UVRI) is partnering with Imperial College London to start the first Covid-19 vaccine trial in the country by December. Prof Pontiano Kaleebu, the UVRI Director, while addressing the daily Monitor news, informed them that they are completing necessary internal processes before beginning to enrol volunteers for the trial. “We are working on a protocol to start a clinical trial for a vaccine that is being developed in the United Kingdom by Imperial College London. The trial will begin by around December.